VILLA, Erica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.564
EU - Europa 8.172
AS - Asia 3.640
SA - Sud America 107
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 18
Totale 36.558
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.478
GB - Regno Unito 2.939
IT - Italia 1.290
SG - Singapore 1.239
SE - Svezia 1.225
CN - Cina 1.056
DE - Germania 958
HK - Hong Kong 491
UA - Ucraina 478
TR - Turchia 469
FI - Finlandia 350
RU - Federazione Russa 256
BG - Bulgaria 255
FR - Francia 140
ID - Indonesia 139
BR - Brasile 76
IN - India 66
BE - Belgio 54
CA - Canada 49
VN - Vietnam 46
IE - Irlanda 43
LT - Lituania 33
NL - Olanda 28
BZ - Belize 26
MY - Malesia 24
ES - Italia 21
EG - Egitto 20
CZ - Repubblica Ceca 18
PL - Polonia 17
EU - Europa 16
JP - Giappone 16
AU - Australia 14
KR - Corea 13
CL - Cile 12
IR - Iran 12
RO - Romania 11
CH - Svizzera 10
AT - Austria 9
ZA - Sudafrica 9
BD - Bangladesh 7
AE - Emirati Arabi Uniti 6
MX - Messico 6
NP - Nepal 6
PE - Perù 6
DK - Danimarca 5
EC - Ecuador 5
HU - Ungheria 5
IL - Israele 5
TH - Thailandia 5
AL - Albania 4
AZ - Azerbaigian 4
IQ - Iraq 4
NZ - Nuova Zelanda 4
AM - Armenia 3
GR - Grecia 3
MA - Marocco 3
PH - Filippine 3
PK - Pakistan 3
PT - Portogallo 3
QA - Qatar 3
RS - Serbia 3
SA - Arabia Saudita 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
CO - Colombia 2
GE - Georgia 2
JO - Giordania 2
LK - Sri Lanka 2
LV - Lettonia 2
NO - Norvegia 2
PA - Panama 2
SS - ???statistics.table.value.countryCode.SS??? 2
TN - Tunisia 2
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GT - Guatemala 1
HR - Croazia 1
IM - Isola di Man 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
ME - Montenegro 1
MK - Macedonia 1
MN - Mongolia 1
NG - Nigeria 1
OM - Oman 1
PY - Paraguay 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
UY - Uruguay 1
Totale 36.556
Salva come PNG Salva come JPEG
Città #
Fairfield 3.542
Santa Clara 2.703
Southend 2.383
Woodbridge 1.967
Houston 1.875
Ashburn 1.833
Chandler 1.653
Seattle 1.338
Wilmington 1.170
Cambridge 1.119
Ann Arbor 1.067
Jacksonville 1.011
Singapore 949
Dearborn 789
Nyköping 738
Hong Kong 484
Modena 480
Izmir 371
San Diego 313
Beijing 267
Princeton 265
Grafing 255
Sofia 254
Helsinki 223
New York 197
Eugene 183
Jakarta 136
Redwood City 130
London 127
Des Moines 110
Shanghai 107
Moscow 99
Bremen 87
Brussels 54
Los Angeles 52
Milan 52
Boardman 51
Falls Church 47
San Jose 47
San Mateo 47
Norwalk 46
Bologna 43
Dublin 40
Munich 40
Chicago 35
Guangzhou 33
Nanjing 33
Fremont 32
Dallas 29
Rome 29
Hefei 28
Belize City 26
Hounslow 26
Carpi 25
Chiswick 24
Kilburn 24
Augusta 23
Dong Ket 23
Philadelphia 23
Frankfurt am Main 22
Paris 22
Ottawa 21
Wuhan 21
Auburn Hills 19
Kunming 19
Lecce 19
Prescot 19
Jinan 18
Toronto 18
Hanoi 17
Brno 15
Leawood 15
Naples 15
Phoenix 14
Saint Louis 14
São Paulo 14
Mountain View 12
Parma 12
Washington 12
Bari 11
Napoli 11
San Francisco 11
Columbus 10
Dongguan 10
Rho 10
Roncoferraro 10
Amsterdam 9
Nanchang 9
Verona 9
Zhengzhou 9
Cascina 8
Indiana 8
Tanta 8
Atlanta 7
Brooklyn 7
Lappeenranta 7
Mumbai 7
Padova 7
Reggio Emilia 7
Ardabil 6
Totale 29.676
Salva come PNG Salva come JPEG
Nome #
Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease 596
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 323
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals 320
Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis 308
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study 304
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel 291
Coagulopathy in liver diseases: complication or therapy? 271
PROGRESSIVE ALTERATIONS IN SYSTEMIC AND CARDIOPULMONARY HEMODYNAMICS OCCUR IN PATIENTS WITH CIRRHOSIS AND PREDICT DEATH IN DECOMPENSATED CIRRHOSIS 261
Fulminant onset of spontaneous bacterial peritonitis. 258
Risk factors for hepatocellular carcinoma in Italy. Male sex, hepatitis B virus, non-A non-B infection, and alcohol. 253
ANTICOAGULANT THERAPY IS SAFE AND EFFECTIVE IN PREVENTING PORTAL VEIN THROMBOSIS (PVT) IN ADVANCED CIRRHOTIC PATIENTS: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 251
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 242
Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: A randomized, controlled trial 242
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis 238
Cardiopulmonary hemodynamics and c-reactive protein as prognostic indicators in compensated and decompensated cirrhosis 237
Alcohol and Hepatitis B Virus Infection 233
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome 230
Acute hepatitis B caused by a vaccine-escape HBV strain in vaccinated subject: sequence analysis and therapeutic strategy 217
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 217
Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women 215
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 214
High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: Long term results of a prospective randomized trial 212
Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort 208
Intestinal/multivisceral transplantation: University of Modena experience 207
Missed treatment in an Italian HBV infected patients cohort: HBV RER 206
Translating pharmacogenetics into clinical practice: interleukin (IL)28B and inosine triphosphatase (ITPA) polymophisms in hepatitis C virus (HCV) infection. 204
Methylprednisolone-induced toxic hepatitis after intravenous pulsed therapy for multiple sclerosis relapses 204
Treatment of nonalcoholic steatohepatitis in adults: present and future 200
Pretransplantation pre-S2 and S protein heterogeneity predisposes to hepatitis B virus recurrence after liver transplantation 199
Anticoagulation in cirrhosis: a new paradigm? 198
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 195
Experimental hepatology applied to stem cells 194
Obese zebrafish: A small fish for a major human health condition 194
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 193
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 192
SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer 192
Reproductive status is associated with the severity of fibrosis in women with hepatitis C. 191
Outcomes after adult isolated small bowel transplantation: experience from a single European centre. 190
Successful liver transplantation in a patient with splanchnic vein thrombosis and pulmonary embolism due to polycythemia vera with Jak2v617f mutation and heparin-induced thrombocytopenia. 190
Interleukin 28B genotype determination using DNA from different sources: A simple and reliable tool for the epidemiological and clinical characterization of hepatitis C. 190
Low molecular weight heparin does not increase bleeding and mortality post endoscopic variceal band ligation in cirrhotic patients 189
The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury 189
Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. 189
Hepatic allograft salvage with early Doppler ultrasound diagnosis of acute vena cava thrombosis 188
De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients 188
Influence of age and gender before and after liver transplantation 188
Glecaprevir/Pibrentasvir in Patients with Chronic HCV Genotype 3 Infection: An Integrated Phase 2/3 Analysis 188
ENOXAPARIN PREVENTS PORTAL VEIN THROMBOSIS (PVT) AND DECOMPENSATION IN ADVANCED CIRRHOTIC PATIENTS: FINAL REPORT OF A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 187
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 187
Selection of more pathogenic hepatitis C virus genotype II during long-term follow-up of interferon-treated patients. 186
Complete resolution of non-necrotizing lung granuloma and pyoderma gangrenosum after restorative proctocolectomy in a woman with severe ulcerative colitis and cytomegalovirus infection 185
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program 185
Efficacy of a Novel Granulocyte Monocyte Apheresis Adsorber Device in the Treatment of Inflammatory Bowel Diseases: A Pilot Study 184
BactDNA as an Independent Risk Factor for Short-Term Crohn's Disease Recurrence 184
Predominance of pre-S1 mutated hepatitis B virus in a patient following treatment with adefovir dipivoxil 184
Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C 184
Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis 183
Prevention and Management of Bleeding Risk Related to Invasive Procedures in Cirrhosis 183
Orthogonal polarization spectral imaging: A new tool in morphologic surveillance in intestinal transplant recipients 182
No inflammation? No cancer! Clear HBV early and live happily. 182
Circulating TGF-β1-related biomarkers in patients with hepatocellular carcinoma and their association with HCC staging scores 182
AISF position paper on liver disease and pregnancy 182
Massive GI bleeding due to accidental ASA inhalation. 181
Menopause, and not age, is a critical factor associated with a worse response to antiviral therapy in women affected by chronic hepatitis C 181
Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients? 181
EVIDENCE FOR HEPATITIS-B VIRUS-INFECTION IN PATIENTS WITH CHRONIC HEPATITIS-C WITH AND WITHOUT SEROLOGICAL MARKERS OF HEPATITIS-B 181
Natural history of chronic HBV infection: special emphasis on the prognostic implications of the inactive carrier state versus chronic hepatitis. 181
From current status to optimization of HCV treatment: Recommendations from an expert panel 180
Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: a long-term cohort study 179
Ethanol-induced increase in cytosolic estrogen receptors in human male liver: a possible explanation for biochemical feminization in chronic liver disease due to alcohol. 177
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) 176
PROCALCITONIN IS THE BEST DIAGNOSTIC AND PROGNOSTIC MARKER OF SEPSIS IN DECOMPENSATED CIRRHOTIC PATIENTS 176
Thrombophilic genetic risk factors for liver fibrosis: To screen or not to screen? 175
Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference 175
Clinical staging systems for hepatocellular carcinoma: Comparison with estrogen receptor classification 174
Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2 174
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical Trials 174
HEPATITIS-B VIRUS SPECIFIC TRANSCRIPTS IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS 173
Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant 173
Estrogen receptor classification for hepatocellular carcinoma: Comparison with clinical staging systems 170
Reply to: “Relationship of hyperdynamic circulation and cardiodynamic states in cirrhosis” 170
HCV RNA IN SERUM OF ASYMPTOMATIC BLOOD-DONORS INVOLVED IN POSTTRANSFUSION HEPATITIS (PTH) 170
Variant estrogen receptors and their role in liver disease 169
Estrogen receptor alpha mRNA variant lacking exon 5 is co-expressed with the wild-type in endometrial adenocarcinoma 169
"Blindly" ADA Dose Escalation to 80 mg Weekly in Crohn's Disease Patients with LOR: Is It Cost Effective or Not? 168
Current and future challenges in HCV: insights from an Italian experts panel 168
Hepatitis B virus infection of peripheral blood mononuclear cells is common in acute and chronic hepatitis. 167
Anticoagulation in cirrhosis. 167
Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer 166
Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy. 165
Biology of hepatocellular carcinoma 165
Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical Perspectives 165
Variant liver estrogen receptor transcripts already occur at an early stage of chronic liver disease 164
Deregulated neddylation in liver fibrosis 164
HEPATITIS-C VIRUS TESTING IN PRIMARY BILIARY-CIRRHOSIS 163
LOW MOLECULAR WEIGHT HEPARIN TREATMENT DOES NOT INCREASE THE RISK OF BLEEDING AFTER PROPHYLACTIC ENDOSCOPIC VARICEAL BAND LIGATION IN PATIENTS WITH CIRRHOSIS 163
Susceptibility of chronic symptomless HBsAg carriers to ethanol-induced hepatic damage. 162
PRESENCE OF HCV RNA IN SERUM OF ASYMPTOMATIC BLOOD-DONORS INVOLVED IN POSTTRANSFUSION HEPATITIS (PTH) 161
Estrogens receptors and oxidative damage in the liver 161
Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool 160
Totale 20.047
Salva come PNG Salva come JPEG
Categoria #
all - tutte 168.904
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 168.904
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.168 0 0 0 0 0 0 1.052 616 635 257 364 244
2020/20217.015 401 309 430 650 820 568 936 958 393 691 552 307
2021/20224.912 334 550 347 283 133 262 507 266 501 407 847 475
2022/20234.569 560 524 352 435 501 710 60 417 535 44 204 227
2023/20242.622 118 177 211 278 458 218 239 327 64 52 156 324
2024/20254.888 339 100 140 729 2.037 1.520 23 0 0 0 0 0
Totale 36.976